The novel treatment of this peptide represents a major advance in the management of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and glucose-dependent https://tirzepatidepeptide839134.dgbloggers.com/42443411/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment